Literature DB >> 9155583

Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.

M M Haapamäki1, J M Grönroos, H Nurmi, K Alanen, M Kallajoki, T J Nevalainen.   

Abstract

BACKGROUND: It has been suggested that phospholipase A2 (PLA2) has an essential role in the pathogenesis of inflammatory bowel diseases. AIMS: This study aimed at identifying cells in intestinal and mesenteric tissue samples that might express group II phospholipase A2 (PLA2-II) at the mRNA and enzyme protein levels in patients with ulcerative colitis. PATIENTS AND TISSUE SAMPLES: Tissue samples were obtained from the intestine, mesentery, skeletal muscle, and subcutaneous fat of six patients who underwent panproctocolectomy for severe ulcerative colitis. Mucosal biopsy specimens were obtained from the colon of another group of six patients with ulcerative colitis during routine diagnostic colonoscopies. Tissues from six patients without intestinal inflammatory diseases served as controls.
METHODS: Tissue samples were studied by light microscopy, immunohistochemistry for PLA2-II enzyme protein, and in situ hybridisation and northern hybridisation for PLA2-II mRNA.
RESULTS: PLA2-II mRNA and PLA2-II protein were detected in metaplastic Paneth cells in six patients and in the columnar epithelial cells of colonic mucosa in four out of six patients with active ulcerative colitis. Positive findings were less numerous in patients with mild ulcerative colitis. Only two out of six control patients had a weak positive signal for PLA2-II mRNA and one of these two patients had a weak positive immunoreaction for PLA2-II in columnar epithelial cells in the colonic mucosa. None of the control patients had metaplastic Paneth cells.
CONCLUSIONS: Metaplastic Paneth cells and colonic epithelial cells synthesise PLA2-II in ulcerative colitis. The activity of the PLA2-II synthesis seems to be related to the degree of inflammation in the diseased bowel.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155583      PMCID: PMC1027015          DOI: 10.1136/gut.40.1.95

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.

Authors:  W Pruzanski; S Saito; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

6.  Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.

Authors:  G C Wright; J Weiss; K S Kim; H Verheij; P Elsbach
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids.

Authors:  J S Bomalaski; D G Baker; L Brophy; N V Resurreccion; I Spilberg; M Muniain; M A Clark
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

8.  Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.

Authors:  J J Seilhamer; W Pruzanski; P Vadas; S Plant; J A Miller; J Kloss; L K Johnson
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

9.  Structure and properties of a human non-pancreatic phospholipase A2.

Authors:  R M Kramer; C Hession; B Johansen; G Hayes; P McGray; E P Chow; R Tizard; R B Pepinsky
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

10.  Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.

Authors:  J Benveniste; M Chignard; J P Le Couedic; B B Vargaftig
Journal:  Thromb Res       Date:  1982-03-01       Impact factor: 3.944

View more
  21 in total

Review 1.  Paneth cells: their role in innate immunity and inflammatory disease.

Authors:  D A Elphick; Y R Mahida
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

2.  In vivo imaging of zebrafish digestive organ function using multiple quenched fluorescent reporters.

Authors:  Kotaro Hama; Elayne Provost; Timothy C Baranowski; Amy L Rubinstein; Jennifer L Anderson; Steven D Leach; Steven A Farber
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

3.  Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa.

Authors:  R N Cunliffe; M Kamal; F R A J Rose; P D James; Y R Mahida
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Altered epithelial cell lineage allocation and global expansion of the crypt epithelial stem cell population are associated with ileitis in SAMP1/YitFc mice.

Authors:  Alda Vidrich; Jenny M Buzan; Sean Barnes; Brian K Reuter; Kirstin Skaar; Chibuzo Ilo; Fabio Cominelli; Theresa Pizarro; Steven M Cohn
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

5.  Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.

Authors:  P García Pastor; S De Rosa; A De Giulio; M Payá; M J Alcaraz
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

6.  The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.

Authors:  Tuulia Avoranta; Jari Sundström; Eija Korkeila; Kari Syrjänen; Seppo Pyrhönen; Jukka Laine
Journal:  Virchows Arch       Date:  2010-10-12       Impact factor: 4.064

7.  Genistein, a potent inhibitor of secretory phospholipase A2: a new insight in down regulation of inflammation.

Authors:  Kattepura K Dharmappa; Riyaz Mohamed; Holenarasipura V Shivaprasad; Bannikuppe Sannanaik Vishwanath
Journal:  Inflammopharmacology       Date:  2009-11-06       Impact factor: 4.473

8.  Distinct isoforms of phospholipase A2 mediate the ability of Salmonella enterica serotype typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils.

Authors:  Karen L Mumy; Jeffrey D Bien; Michael A Pazos; Karsten Gronert; Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

9.  Computational modeling and in-vitro/in-silico correlation of phospholipid-based prodrugs for targeted drug delivery in inflammatory bowel disease.

Authors:  Arik Dahan; Milica Markovic; Shahar Keinan; Igor Kurnikov; Aaron Aponick; Ellen M Zimmermann; Shimon Ben-Shabat
Journal:  J Comput Aided Mol Des       Date:  2017-11-03       Impact factor: 3.686

10.  Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.

Authors:  Christine Lagorce-Pagès; François Paraf; Dominique Wendum; Antoine Martin; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-03-25       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.